Drugs / METHIONINE
METHIONINE
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | EU (EMA) | Maapliv | — | 2025-07-28 | europa.eu ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT00226356 | Dec 2004 → Jun 2007 | major depressive disorder | Cambridge Health Alliance | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| — | NCT02216253 Comparator | Oct 2014 → Aug 2015 | pelvic organ prolapse, urinary tract infection | IRCCS San Raffaele | Completed | No outcome recorded |
| — | NCT01208324 Comparator | Mar 2010 → Nov 2018 | premature menopause | University of Colorado, Denver | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | METHIONINE | ChEMBL registry synonym — accepted as the source's own label CHEMBL42336 ↗ |
| Known as | L-methionine | “L-Methionine (1.5 g)” NCT01208324 ↗ |
| Known as | METHIONINE C 11 | ChEMBL registry synonym — accepted as the source's own label CHEMBL42336 ↗ |
| Known as | Metionina | ChEMBL registry synonym — accepted as the source's own label CHEMBL42336 ↗ |
| Known as | NSC-22946 | ChEMBL registry synonym — accepted as the source's own label CHEMBL42336 ↗ |
| Modality | Small molecule | — CHEMBL42336 ↗ |
| Route | Oral | “Each test day will involve the ingestion of 70 capsules.” NCT01208324 ↗ |